Global Alcohol Breathalyzer and Drug Testing Equipment Market, byProduct Type (Immunoassay Analyzers, Chromatography Instruments, Breathalyzers, Oral Fluid Testing Devices, Urine Testing Devices, and Others), by Sample Type (Urine, Breathe, Saliva, and Hair), by End User (Hospitals, Federal Departments, Rehabilitation Centers, Private Sectors, and Others) and by Region(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 4,765.6 Million in 2017 and is projected to exhibit a CAGR of 8.4% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights. The alcohol breathalyzer and drug testing equipment market is expected to gain significant traction, owing to increasing number of research undertaken by organizations to developed ultra-sensitive technology for non-invasive breath measurement.

Researchers are discovering new treatment options for providing low cost alcohol monitoring device that sends data to doctors and can drastically reduce healthcare expenses in addiction treatment, which in turn is expected to augment the alcohol breathalyzer and drug testing equipment market size. For instance, in January 2017, BACtrack, launched BACtrack Skyn, the world’s first wearable alcohol monitor that measures alcohol eliminated through the skin continuously and in near real-time. BACtrack Skyn has the potential to have an enormous impact on health and safety at individual and societal level as more than 10,000 Americans die due to alcohol-related auto accidents annually, thereby raising the adoption of real-time, user friendly device that can track sobriety and share results.

Moreover, in 2016, Soberlink Healthcare, LLC, received 510(k) premarket clearance from the U.S. Food and Drug Administration (FDA) for Soberlink Breathalyzer for medical use by healthcare providers to remotely measure alcohol in human breath, in order to aid in the detection and monitoring of alcohol consumption for those suffering from alcohol use disorders.

Key players are focused on research and development to introduce innovative products for enhancing roadside drug detection, by developing a portable solution for the convenience of the public defenders, thus, increasing adoption of these technologically advanced devices leading to growth of the market. For instance, in 2017, Hound Labs, Inc. was the first company to rapidly and inexpensively detect marijuana use and alcohol level in a person’s breath. Using only one or two breaths, the devices detects THC and measures levels to well below 500 picograms or parts-per-trillion (ppt). The company’s scientific breakthrough has been optimized to create a prototype of the first dual alcohol and marijuana breathalyzer for use by law enforcement at the roadside.

Moreover, increasing number of collaborations between manufacturers to develop innovative devices is a major factor augmenting the market growth. For instance, in 2017, MAP Health Management, LLC, collaborated with Soberlink Healthcare, LLC. to remotely track real-time breathalyzer results for patients with an Alcohol Use Disorder (AUD).

The global alcohol breathalyzer and drug testing equipment market is expected to exhibit a CAGR of 8.4% over the forecast period, owing to increasing number of laws enforced to prevent driving after alcohol consumption and increasing number for fatal accidents

Among end user, hospital segment is expected to hold dominant position in the alcohol breathalyzer and drug testing equipment market over the forecast period, owing to increasing incidence of alcohol use disorder and rising adoption of the portable breathe analyzers in the medical setting for effective treatment